Target intelligence / Profile preview

Immunoglobulin heavy variable 3-23 pseudogene (IGHV3-23P)

Target
IGHV3-23P
Molecular classification
Other, Immunoglobulin pseudogene
01

Overview

Immunoglobulin heavy variable 3-23 pseudogene (often abbreviated as IGHV3-23P) is a nonfunctional genomic sequence belonging to the immunoglobulin heavy chain variable region gene family. Pseudogenes such as this are characterized by their inability to encode a functional protein product due to disabling mutations like premature stop codons, frameshifts, or altered splicing sites. The IGHV locus in humans comprises both functional variable gene segments, which undergo V(D)J recombination to contribute to antibody diversity, and nonfunctional pseudogenes, which may serve as genetic reservoirs for recombination but are not themselves translated into functional immunoglobulin chains. This pseudogene does not participate in immune responses, signal transduction, or serve as a therapeutic drug target, and is not implicated in human disease pathways as a causative or therapeutic entity. Its main relevance is as a marker of gene family organization and evolution, rather than clinical utility.

Other names
IGHV3-23PImmunoglobulin heavy chain variable region pseudogene 3-23
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, no direct function; potentially contributes to antibody gene diversity via gene conversion or recombination, but does not have an independent molecular function)
04

Disease associations

Other (No direct role; pseudogenes may occasionally serve as templates for genetic diversity in some species, but there is no validated disease association or therapeutic role for this specific pseudogene)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-23 pseudogene (IGHV3-23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-23 pseudogene (IGHV3-23P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call